Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.

Simpson EL, Ren S, Hock ES, Stevens JW, Binard A, Pers YM, Archer R, Paisley S, Stevenson MD, Herpin C, Ghabri S.

Int J Technol Assess Health Care. 2019 Feb 6:1-9. doi: 10.1017/S0266462318003628. [Epub ahead of print]

2.

A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients.

Luxembourger C, Ruyssen-Witrand A, Ladhari C, Rittore C, Degboe Y, Maillefert JF, Gaudin P, Marotte H, Wendling D, Jorgensen C, Cantagrel A, Constantin A, Nigon D, Touitou I, Gottenberg JE, Pers YM.

Pharmacogenomics J. 2019 Jan 16. doi: 10.1038/s41397-019-0072-6. [Epub ahead of print]

PMID:
30647443
3.

[Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis].

Maumus M, Pers YM, Ruiz M, Jorgensen C, Noël D.

Med Sci (Paris). 2018 Dec;34(12):1092-1099. doi: 10.1051/medsci/2018294. Epub 2019 Jan 9. French.

PMID:
30623767
4.

Delivery of miR-146a to Ly6Chigh Monocytes Inhibits Pathogenic Bone Erosion in Inflammatory Arthritis.

Ammari M, Presumey J, Ponsolles C, Roussignol G, Roubert C, Escriou V, Toupet K, Mausset-Bonnefont AL, Cren M, Robin M, Georgel P, Nehmar R, Taams L, Grün J, Grützkau A, Häupl T, Pers YM, Jorgensen C, Duroux-Richard I, Courties G, Apparailly F.

Theranostics. 2018 Nov 13;8(21):5972-5985. doi: 10.7150/thno.29313. eCollection 2018.

5.

Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy.

Ladhari C, Jorgensen C, Pers YM.

Rheumatology (Oxford). 2018 Dec 24. doi: 10.1093/rheumatology/key414. [Epub ahead of print] No abstract available.

PMID:
30590753
6.

Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells.

Pers YM, Quentin J, Feirreira R, Espinoza F, Abdellaoui N, Erkilic N, Cren M, Dufourcq-Lopez E, Pullig O, Nöth U, Jorgensen C, Louis-Plence P.

Theranostics. 2018 Nov 5;8(20):5519-5528. doi: 10.7150/thno.27674. eCollection 2018.

7.

TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis.

Ruiz M, Maumus M, Fonteneau G, Pers YM, Ferreira R, Dagneaux L, Delfour C, Houard X, Berenbaum F, Rannou F, Jorgensen C, Noël D.

Osteoarthritis Cartilage. 2018 Nov 28. pii: S1063-4584(18)31547-4. doi: 10.1016/j.joca.2018.11.005. [Epub ahead of print]

PMID:
30502449
8.

Contribution of microRNAs to the immunosuppressive function of mesenchymal stem cells.

Pers YM, Maumus M, Bony C, Jorgensen C, Noël D.

Biochimie. 2018 Dec;155:109-118. doi: 10.1016/j.biochi.2018.07.001. Epub 2018 Jul 6. Review.

PMID:
30477691
9.

Development and Validation of a Self-Administered Multidimensional Prognostic Index to Predict Negative Health Outcomes in Community-Dwelling Persons.

Pilotto A, Veronese N, Quispe Guerrero KL, Zora S, Boone ALD, Puntoni M, Giorgeschi A, Cella A, Hidalgo IR, Pers YM, Ferri A, Fernandez JRH, Pisano Gonzalez M; EFFICHRONIC Consortium.

Rejuvenation Res. 2018 Dec 28. doi: 10.1089/rej.2018.2103. [Epub ahead of print]

PMID:
30382001
10.

Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1.

Berger J, Vigan M, Pereira B, Nguyen TT, Froissart R, Belmatoug N, Dalbiès F, Masseau A, Rose C, Serratrice C, Pers YM, Bertchansky I, Camou F, Bengherbia M, Bourgne C, Caillaud C, Pettazzoni M, Berrahal A, Stirnemann J, Mentré F, Berger MG.

Clin Pharmacokinet. 2018 Aug 21. doi: 10.1007/s40262-018-0708-8. [Epub ahead of print]

PMID:
30128966
11.

Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM.

Drug Saf. 2018 Oct;41(10):919-931. doi: 10.1007/s40264-018-0689-4.

PMID:
29858838
12.

Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study.

Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP).

Clin Pharmacol Ther. 2018 Aug;104(2):317-325. doi: 10.1002/cpt.962. Epub 2018 Jan 30.

13.

Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.

Vidal C, Lukas C, Combe B, Berenbaum F, Pers YM, Jorgensen C, Sellam J, Morel J.

Joint Bone Spine. 2018 Jul;85(4):461-468. doi: 10.1016/j.jbspin.2017.08.005. Epub 2017 Sep 14.

PMID:
28917996
14.

Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.

Holubar J, Bres V, Costes-Martineau V, Pers YM.

Blood Cells Mol Dis. 2018 Feb;68:112-114. doi: 10.1016/j.bcmd.2017.05.010. Epub 2017 May 24. No abstract available.

PMID:
28559130
15.

Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea.

Pers YM, Sow MS, Taverne B, March L, Izard S, Étard JF, Barry M, Touré A, Delaporte E.

Rheumatology (Oxford). 2017 Dec 1;56(12):2068-2072. doi: 10.1093/rheumatology/kex074.

PMID:
28371810
16.

TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin.

Khalifa O, Balandraud N, Lambert N, Auger I, Roudier J, Sénéchal A, Geneviève D, Picard C, Lefranc G, Touitou I, Mrenda BM, Benedito C, Pardoux E, Gagez AL, Pers YM, Jorgensen C, Mahjoub T, Apparailly F.

J Immunol Res. 2017;2017:4915950. doi: 10.1155/2017/4915950. Epub 2017 Feb 8.

17.

Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.

Etard JF, Sow MS, Leroy S, Touré A, Taverne B, Keita AK, Msellati P, Magassouba N, Baize S, Raoul H, Izard S, Kpamou C, March L, Savane I, Barry M, Delaporte E; Postebogui Study Group.

Lancet Infect Dis. 2017 May;17(5):545-552. doi: 10.1016/S1473-3099(16)30516-3. Epub 2017 Jan 14.

PMID:
28094208
18.

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

Bousquet J, Bourret R, Camuzat T, Augé P, Bringer J, Noguès M, Jonquet O, de la Coussaye JE, Ankri J, Cesari M, Guérin O, Vellas B, Blain H, Arnavielhe S, Avignon A, Combe B, Canovas G, Daien C, Dray G, Dupeyron A, Jeandel C, Laffont I, Laune D, Marion C, Pastor E, Pélissier JY, Galan B, Reynes J, Reuzeau JC, Bedbrook A, Granier S, Adnet PA, Amouyal M, Alomène B, Bernard PL, Berr C, Caimmi D, Claret PG, Costa DJ, Cristol JP, Fesler P, Hève D, Millot-Keurinck J, Morquin D, Ninot G, Picot MC, Raffort N, Roubille F, Sultan A, Touchon J, Attalin V, Azevedo C, Badin M, Bakhti K, Bardy B, Battesti MP, Bobia X, Boegner C, Boichot S, Bonnin HY, Bouly S, Boubakri C, Bourrain JL, Bourrel G, Bouix V, Bruguière V, Cade S, Camu W, Carre V, Cavalli G, Cayla G, Chiron R, Coignard P, Coroian F, Costa P, Cottalorda J, Coulet B, Coupet AL, Courrouy-Michel MC, Courtet P, Cros V, Cuisinier F, Danko M, Dauenhauer P, Dauzat M, David M, Davy JM, Delignières D, Demoly P, Desplan J, Dujols P, Dupeyron G, Engberink O, Enjalbert M, Fattal C, Fernandes J, Fouletier M, Fraisse P, Gabrion P, Gellerat-Rogier M, Gelis A, Genis C, Giraudeau N, Goucham AY, Gouzi F, Gressard F, Gris JC, Guillot B, Guiraud D, Handweiler V, Hayot M, Hérisson C, Heroum C, Hoa D, Jacquemin S, Jaber S, Jakovenko D, Jorgensen C, Kouyoudjian P, Lamoureux R, Landreau L, Lapierre M, Larrey D, Laurent C, Léglise MS, Lemaitre JM, Le Quellec A, Leclercq F, Lehmann S, Lognos B, Lussert CM, Makinson A, Mandrick K, Mares P, Martin-Gousset P, Matheron A, Mathieu G, Meissonnier M, Mercier G, Messner P, Meunier C, Mondain M, Morales R, Morel J, Mottet D, Nérin P, Nicolas P, Nouvel F, Paccard D, Pandraud G, Pasdelou MP, Pasquié JL, Patte K, Perrey S, Pers YM, Portejoie F, Pujol JL, Quantin X, Quéré I, Ramdani S, Ribstein J, Rédini-Martinez I, Richard S, Ritchie K, Riso JP, Rivier F, Robine JM, Rolland C, Royère E, Sablot D, Savy JL, Schifano L, Senesse P, Sicard R, Stephan Y, Strubel D, Tallon G, Tanfin M, Tassery H, Tavares I, Torre K, Tribout V, Uziel A, Van de Perre P, Venail F, Vergne-Richard C, Vergotte G, Vian L, Vialla F, Viart F, Villain M, Viollet E, Ychou M, Mercier J.

J Frailty Aging. 2016;5(4):233-241.

PMID:
27883170
19.

Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health.

Keita AK, Toure A, Sow MS, Raoul H, Magassouba N, Delaporte E, Etard JF; POSTEBOGUI Study Group.

Clin Microbiol Infect. 2017 Jun;23(6):412-413. doi: 10.1016/j.cmi.2016.11.005. Epub 2016 Nov 17. No abstract available.

20.

X-Linked miRNAs Associated with Gender Differences in Rheumatoid Arthritis.

Khalifa O, Pers YM, Ferreira R, Sénéchal A, Jorgensen C, Apparailly F, Duroux-Richard I.

Int J Mol Sci. 2016 Nov 8;17(11). pii: E1852.

Supplemental Content

Loading ...
Support Center